Cytori Therapeutics, Inc. Announces Closing of Financing – MarketWatch

Cytori Therapeutics, Inc. Announces Closing of Financing
MarketWatch
The preferred stock is convertible into shares of Cytori’s common stock at the option of the investors at a conversion price of $0.52. Cytori also issued warrants to purchase an aggregate of 25,961,541 shares of Cytori’s common stock at an exercise

and more

…read more

Scroll to Top